ProQR Therapeutics
PRQR
PRQR
50 hedge funds and large institutions have $125M invested in ProQR Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.56M | |
| 2 | +$2.45M | |
| 3 | +$487K | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$477K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$369K |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$4.55M | |
| 3 | -$3.13M | |
| 4 |
ClearBridge Investments
New York
|
-$2.91M |
| 5 |
Jennison Associates
New York
|
-$1.32M |